Image 1
Propafenone Hcl
Product Images NDC 0591-0583
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Propafenone Hcl (NDC 0591-0583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a description of Propafenone Hydrochloride Tablets USP, which are prescription drugs manufactured in India by Watson Pharma Private Limited and distributed in the USA by Actavis Pharma, Inc. Each tablet contains Propafenone Hydrochloride, USP 150mg. The usual dosage and full prescribing information can be found in the packaging insert. The drug should be stored in a tight, light-resistant container at a temperature between 20°C to 25°C and relative humidity below 60%. The lot/exp number is 0591-0582-01 and the non-varnish/coding area has two lines of unreadable text.*
Image 3
Propafenone Hydrochloride is a medication that comes in tablet form with 225mg USP strength. It is packaged with 100 tablets in a container that should be dispensed in a tightly-sealed container that has light protection. The normal dosage is provided in the package insert. The tablets should be stored between 20°C to 25°C with relative humidity under 60%. This medication is distributed by Actavis Pharma, Inc from Parsippany, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
